Lifecore Biomedical, Inc.
LFCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001005286
No open-market purchases or sales by Lifecore Biomedical, Inc. insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Lifecore Biomedical, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 86 | 93 | +7 |
| Shares | 24.7M | 24.7M | −57.5K (−0.2%) |
| Value | $220.0M | $160.0M | −$60.0M (−27.3%) |
New holders (10)
Institutions that held Lifecore Biomedical, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 167,115 | $1.08M | 0.01% |
| Citadel Advisors LLC | 83,755 | $542.7K | 0.00% |
| Susquehanna International Group, LLP | 18,327 | $118.8K | 0.00% |
| Squarepoint Ops LLC | 17,789 | $115.3K | 0.00% |
| Legato Capital Management LLC | 15,354 | $99.5K | 0.02% |
| Jump Financial, LLC | 12,200 | $79.1K | 0.00% |
| Point72 Middle East FZE | 930 | $6.03K | 0.00% |
| Ellevest, Inc. | 294 | $1.91K | 0.00% |
| CWM, LLC | 223 | $1.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 109 | $706 | 0.00% |
Sold out (3)
Institutions that held Lifecore Biomedical, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Smith, Moore & Co. | 10,500 | $93.0K |
| Bessemer Group Inc | 4,000 | $36.0K |
| Point72 Hong Kong Ltd | 855 | $8.00K |